NJOY, an independent e-cigarette and vaping company, on Monday announced the appointment of Paul Sturman as its new CEO and president.
Sturman joins the company from Pfizer's consumer healthcare business where he served as global president and general manager. Sturman was responsible for the $3 billion division's global operations, which included development and marketing of such household brands as Advil, Centrum, Chapstick and Robitussin. Before joining Pfizer, he was president of Johnson & Johnson's North American consumer healthcare unit.